Latest filing published 13 Aug 2009 for ANGIOTECH PHARMACEUTICALS INC, €2,369.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jonathan W. Chen: trading record in brief
This profile gathers the share dealings of Jonathan W. Chen in Angiotech Pharmaceuticals Inc. Activity is concentrated on a single trading day, 12 August 2009, with 4 filings.
Every open-market trade on record is a purchase: 4 purchases worth €14k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
In size, the median ticket on the buying side is €2,982.
Most recently, on 13 August 2009, the filings show an open-market purchase worth €2,369 in Angiotech Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jonathan W. Chen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,900 shares@ US$1.78Common StockSEC:0001096481-09-000028:0Canonical exit: 10 Nov 2009 (T+90)
- 5,200 shares@ US$1.76Common StockSEC:0001096481-09-000028:1Canonical exit: 10 Nov 2009 (T+90)
- 2,900 shares@ US$1.77Common StockSEC:0001096481-09-000028:2Canonical exit: 10 Nov 2009 (T+90)
- 1,100 shares@ US$1.78Common StockSEC:0001096481-09-000028:3Canonical exit: 10 Nov 2009 (T+90)
4 of 4 declarations